By Editor , 10 September 2026
Beta Bionics Faces Class Action Over iLet Insulin Pump Disclosures

San Diego – September 10, 2026 -- Robbins LLP has filed a securities class action against Beta Bionics, Inc. (NASDAQ: BBNX) on behalf of investors who purchased common stock between July 30, 2025 and February 24, 2026, alleging the company misrepresented the safety and commercial viability of its iLet Bionic Pancreas insulin pump.

By Editor , 10 September 2026
Halper Sadeh Probes DexCom Board Over Fiduciary Duty Claims

New York – September 10, 2026 -- Halper Sadeh LLC has launched an investigation into whether officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shareholders.

Law Firm Targets DexCom Governance Practices

The New York-based investor rights firm, operating out of One World Trade Center, is examining potential corporate misconduct at the continuous glucose monitoring device maker. Attorneys Daniel Sadeh and Zachary Halper are leading the inquiry.

By Editor , 10 September 2026

Bensalem, Pa. – September 10, 2026 -- The Law Offices of Howard G. Smith announced a securities fraud class action against Hims & Hers Health, Inc. (NYSE: HIMS), setting a November 2, 2026 lead plaintiff deadline for investors seeking to lead the case.

By Editor , 10 September 2026
Hims & Hers Faces Securities Suit After FTC Data-Sharing Complaint

San Francisco – September 10, 2026 -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain executives now face a securities class action after a July 29, 2026 federal complaint from the Federal Trade Commission wiped over $970 million from the company's market capitalization in a single trading session, sending shares down $4.32, or 14.7%.

By Editor , 10 September 2026
ABDA Sets Munich Press Briefing on Pharmacy Reform Impact

Munich – September 09, 2026 -- More than 300 delegates from Germany's 17 pharmacist chambers and associations will convene in Munich from September 15 to 17 for the German Pharmacists' Day (Deutscher Apothekertag, DAT) 2026, as the country's pharmacy reform moves from legislation into implementation.

By Editor , 10 September 2026
NGO Warns AfD's Saxony-Anhalt Win Threatens Healthcare Access

Munich – – September 09, 2026 -- Medical relief organization Ärzte der Welt has warned that the AfD's election victory in Saxony-Anhalt could jeopardize healthcare access for vulnerable populations across Germany, citing risks to uninsured patients, refugee families and homeless individuals.

By Editor , 10 September 2026
DKOU 2026 Opens Registration, Targets Orthopedic Workforce Gap

Berlin – September 09, 2026 -- The German Congress for Orthopaedics and Trauma Surgery (DKOU) 2026 has published its full program and opened registration, with the four-day event set to run October 20-23, 2026 at CityCube Berlin.

By Editor , 10 September 2026
Sky Labs' CART Ring Hits 300,000 Prescriptions, Enters Korea BP Guidelines

Munich – September 09, 2026 -- Sky Labs presented new clinical data at ESC Congress 2026 showing its ring-shaped blood pressure monitor, CART, achieves an approximately 80% data-usability rate in continuous 24-hour monitoring of patients with atrial fibrillation, addressing a measurement gap left by traditional cuff-based devices in patients with irregular pulse or severe blood pressure fluctuations.

By Editor , 10 September 2026
Sky Labs' CART Ring Validated for AFib, Heart Failure BP Monitoring

Munich – September 09, 2026 -- Sky Labs unveiled new clinical data at ESC Congress 2026 showing its ring-shaped blood pressure monitor CART achieved an 80% data evaluability rate in 24-hour monitoring of patients with atrial fibrillation (AFib), addressing a gap where conventional cuffs struggle with irregular pulses.

By Editor , 10 September 2026
Sky Labs' CART Ring Shows 80% Data Accuracy in AFib, Heart Failure Trials

Munich – September 09, 2026 -- Sky Labs presented new clinical trial data for its ring-based blood pressure monitor, CART, at the ESC Congress 2026 in Munich on September 7, showing an 80% data evaluability rate in continuous monitoring of atrial fibrillation (AFib) patients and high correlation with standard ambulatory blood pressure monitoring (ABPM) in severe heart failure cases.